Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32 httpdlvr.itQnsC1KÂpic.twitter.comyDG6YUyuWr

Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32% http://dlvr.it/QnsC1K pic.twitter.com/yDG6YUyuWr

13:26 EDT 19 Oct 2018 | Biotechnology Twitter

Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32% http://dlvr.it/QnsC1K  pic.twitter.com/yDG6YUyuWr

More From BioPortfolio on "Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32% http://dlvr.it/QnsC1K pic.twitter.com/yDG6YUyuWr"